Centrovet
Date: Nov 2012
Client: Centrovet
Counterparty: Virbac
Industry: Healthcare
Amount: Undisclosed amount
Transaction:
Landmark Alantra advised the shareholders of Centrovet, the leading Chilean laboratory of veterinary vaccines and pharmaceuticals, in the structuring and execution of a strategic partnership and joint venture with the French animal health company, Virbac S.A.
Nov 2012
Financial advisor to
on the sale of 51% of the shares to
Undisclosed amount
Similar transactions
Nov 2021
Financial advisor to
on the sale of 34% of the shares to
With this transaction, Virbac completes the acquisition of 100% of the company since the initial purchase in 2012
Leer más
